Annual Congress Amsterdam 2011

Saturday, 24.09.2011
Sunday, 25.09.2011
Monday, 26.09.2011
Tuesday, 27.09.2011
Wednesday, 28.09.2011

Citations should be made in the following way: Authors. Title. Eur Respir J 2011; 38: Suppl. 55, abstract number.

Material from 2011

4205 Abstracts
632 Slide presentations
250 Webcasts
66 Handouts
1703 e-posters
250 Multimedia files

Material from 2011 Show

Severity, comorbidities and outcomes in community-acquired pneumonia

Oral Presentation
Chairs: A. Torres (Barcelona, Spain), G. Dimopoulos (Athens, Greece)

Download all media

Late-breaking abstract: CAP, HCAP and immunocompromised patients with pneumonia: Should we rethink the concepts? M. Carrabba, M. Zarantonello, C. Hu, P. Bonara, G. Fabio (Milano, Italy)
Weight of the IDSA/ATS minor criteria for severe community-acquired pneumonia Q. Guo, H. Y. Li, Y. P. Zhou, M. Li, X. K. Chen, H. Liu, H. L. Peng, H. Q. Yu, X. Chen, N. Liu, L. H. Liang, Q. Z. Zhao, M. Jiang (Shenzhen, Guangzhou, China)
The impact of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP): Preliminary results from the FAILCAP study L. Morlacchi, S. Aliberti, A. Gramegna, A. Voza, L. Pancini, C. Baumgartner, F. Giuliani, R. Fantini, A. Lasagni, E. Lavezzi, S. Perossi, P. Peyrani, V. Monzani, A. Pesci, J. Ramirez, F. Blasi (Milan, Modena, Monza, Italy; Basel, Switzerland; Louisville, United States Of America)
Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia M. Kolditz, M. Pletz, G. Höffken, on Behalf of the CAPNETZ Study Group (Dresden, Jena, Germany)
A population-based study of statin, ARB, and ACE inhibitor use on pneumonia-related outcomes E. Mortensen, J. Cornell, L. Copeland, B. Nakashima, M. J. Pugh, M. Restrepo, A. Anzueto (San Antonio, United States Of America)
Dysnatremia, vasopressin, atrial natriuretic peptide and mortality in community-acquired pneumonia – Results from the German competence network CAPNETZ S. Krüger, J. Kunde, O. Hartmann, N. Suttorp, G. Rohde, T. Welte (Aachen, Henningsdorf, Berlin, Hannover, Germany; Maastricht, Netherlands)
How to recognize clinical stability in hospitalized patients with community-acquired pneumonia (CAP)? S. Aliberti, T. Wiemken, A. Zanaboni, A. Nahas, S. Uppatla, C. Travierso, F. Giuliani, V. Giunta, G. Salomoni, C. Conti, E. Parazzini, P. Peyrani, F. Blasi, J. Ramirez (Monza, Milan, Italy; Louisville, United States Of America)
Inhaled corticosteroids (ICS), systemic inflammatory response and mortality in community-acquired pneumonia (CAP) M. Ferrer, A. Torres, S. Reyes, R. Martinez, P. Ramirez, E. Polverino, C. Agusti, J. Cordoba, R. Menendez (Barcelona, Valencia, Spain)